Join the Major Depressive Disorder group to help and get support from people like you.
Major Depressive Disorder News (Page 19)
Related terms: Clinical Depression, Unipolar Disorder, MDD
Could Antidepressants Give Memory a Boost?
MONDAY, Sept. 23, 2024 – Antidepressants have the potential to improve memory and thinking skills, a new study suggests. Some patients experienced a boost on brain tests after taking the SSRI...
Partner's Adult ADHD Can Harm a Woman's Mental Health
MONDAY, Sept. 23, 2024 – Having a husband or boyfriend with adult ADHD can harm a woman's mental stability, a new study suggests. About 3 in 5 women (59%) with male partners with...
Many Former NFL Players Believe They Have CTE, Raising Suicide Risk
MONDAY, Sept. 23, 2024 – One in three former NFL players believe they have football-related brain damage that’s doing untold harm to their lives, a new study finds. Unfortunately, their fears might b...
Psilocybin Equals or Exceeds SSRI Antidepressants at Easing Depression
MONDAY, Sept. 23, 2024 – Psilocybin, the active ingredient in magic mushrooms, appears to ease depression symptoms at least as well as one of the most commonly used antidepressants, a new clinical...
Study Explores Demand for Psilocybin-Assisted Therapy in U.S.
WEDNESDAY, Sept. 18, 2024 – The demand for psilocybin-assisted therapy (PSIL-AT) for major depressive disorder (MDD) and treatment-resistant depression (TRD) varies from 24 to 62 percent depending...
Postpartum Anxiety, Depression Not Up After Pandemic Onset, but Benzodiazepine Rx Increased
TUESDAY, Sept. 17, 2024 – Among privately insured women, diagnoses of postpartum anxiety and depression did not increase following onset of the COVID-19 pandemic, but there was an increase in the...
Therapy Dogs Can Ease Nurses', Doctors' Stress, Too
WEDNESDAY, Sept. 18, 2024 – Therapy dogs can help boost the spirits of health care workers in the same way they brighten the moods of hospital patients, a new study shows. The furry, four-legged ...
Childhood Trauma Can Raise Health Risks for a Lifetime
TUESDAY, Sept. 17, 2024 – Deprivation, neglect and abuse during childhood can increase a person’s long-term risk of health problems, a new study warns. “Stress is implicated in nine of the 10 lea...
FDA Approves Exxua (gepirone) for the Treatment of Major Depressive Disorder in Adults
HOUSTON, Sept. 28, 2023 /PRNewswire/ – Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company committed to developing novel therapies to address unmet needs in psychiatry and...
U.S. FDA Approves Vraylar (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder
Approval marks fourth indication for Vraylar, backed by proven efficacy and well-established tolerability as an adjunctive treatment for major depressive disorder (MDD) with an antidepressant...
FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults
Auvelity is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to placebo starting at one week11-4...
FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression
March 5, 2019 – The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have...
FDA Approves Rexulti (brexpiprazole) for Schizophrenia and Adjunctive Treatment for Major Depressive Disorder
Tokyo, Japan and Valby, Denmark – July 11, 2015 –Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced today that the U.S. Food and Drug Administration (FDA) approved Rex...
Actavis Receives FDA Approval for Viibryd (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose
DUBLIN, March 16, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT) today announced the U.S. Food and Drug Administration (FDA) has approved a lower therapeutic dose of Viibryd (vilazodone HCl) (20mg) to...
Further information
Related condition support groups
Related drug support groups
Lexapro, Zoloft, sertraline, Wellbutrin, Cymbalta, trazodone, Prozac, Effexor, escitalopram, view more... bupropion, mirtazapine, Abilify, venlafaxine, fluoxetine, Paxil, Effexor XR, Pristiq, Wellbutrin XL, Viibryd, duloxetine, Trintellix, quetiapine, Remeron, Vraylar, paroxetine, olanzapine, Wellbutrin SR, Zyprexa, vortioxetine, aripiprazole, doxepin, Seroquel XR, Rexulti, Auvelity, desvenlafaxine